Literature DB >> 25458308

Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Michelle M Mielke1, Stephen D Weigand2, Heather J Wiste2, Prashanthi Vemuri3, Mary M Machulda4, Davis S Knopman5, Val Lowe3, Rosebud O Roberts6, Kejal Kantarci3, Walter A Rocca6, Clifford R Jack3, Ronald C Petersen6.   

Abstract

BACKGROUND: Inexpensive, non-invasive tools for assessing Alzheimer-type pathophysiologies are needed. Computerized cognitive assessments are prime candidates.
METHODS: Cognitively normal participants, aged 51-71, with magnetic resonance imaging, fluorodeoxyglucose-positron emission tomography (FDG-PET), amyloid PET, CogState computerized cognitive assessment, and standard neuropsychological tests were included. We first examined the association between the CogState battery and neuroimaging measures. We then compared that association to the one between standard neuropsychological z-scores and neuroimaging.
RESULTS: Slower reaction times for CogState Identification and One Back, and lower memory and attention z-scores, were associated (P < .05) with FDG-PET hypometabolism. Slower time on the Groton Maze Learning Task and worse One Card Learning accuracy were associated (P < .05) with smaller hippocampal volumes. There were no associations with amyloid PET. Associations of CogState and neuropsychological Z-scores with neuroimaging were small and of a similar magnitude.
CONCLUSIONS: CogState subtests were cross-sectionally comparable to standard neuropsychological tests in their relatively weak associations with neurodegeneration imaging markers.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloid-beta; Computerized cognitive battery; Hippocampal volume; Neuroimaging; Neuropsychology; Preclinical Alzheimer's disease

Mesh:

Substances:

Year:  2014        PMID: 25458308      PMCID: PMC4273919          DOI: 10.1016/j.jalz.2014.09.001

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  29 in total

1.  The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals.

Authors:  Alexander Collie; Paul Maruff; David G Darby; Michael McStephen
Journal:  J Int Neuropsychol Soc       Date:  2003-03       Impact factor: 2.892

2.  The effects of growth hormone (GH) deficiency and GH replacement on cognitive performance in adults: a meta-analysis of the current literature.

Authors:  Marina G Falleti; Paul Maruff; Pia Burman; Alan Harris
Journal:  Psychoneuroendocrinology       Date:  2006-04-18       Impact factor: 4.905

3.  The Clinical Dementia Rating (CDR): current version and scoring rules.

Authors:  J C Morris
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Aβ amyloid, cognition, and APOE genotype in healthy older adults.

Authors:  Yen Ying Lim; Kathryn A Ellis; David Ames; David Darby; Karra Harrington; Ralph N Martins; Colin L Masters; Christopher Rowe; Greg Savage; Cassandra Szoeke; Victor L Villemagne; Paul Maruff
Journal:  Alzheimers Dement       Date:  2012-11-14       Impact factor: 21.566

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  The short test of mental status. Correlations with standardized psychometric testing.

Authors:  E Kokmen; G E Smith; R C Petersen; E Tangalos; R C Ivnik
Journal:  Arch Neurol       Date:  1991-07

8.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

9.  The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.

Authors:  Rosebud O Roberts; Yonas E Geda; David S Knopman; Ruth H Cha; V Shane Pankratz; Bradley F Boeve; Robert J Ivnik; Eric G Tangalos; Ronald C Petersen; Walter A Rocca
Journal:  Neuroepidemiology       Date:  2008-02-07       Impact factor: 3.282

Review 10.  Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.

Authors:  Leslie M Shaw; Magdalena Korecka; Christopher M Clark; Virginia M-Y Lee; John Q Trojanowski
Journal:  Nat Rev Drug Discov       Date:  2007-03-09       Impact factor: 84.694

View more
  16 in total

1.  Cognitive, emotion control, and motor performance of adolescents in the NCANDA study: Contributions from alcohol consumption, age, sex, ethnicity, and family history of addiction.

Authors:  Edith V Sullivan; Ty Brumback; Susan F Tapert; Rosemary Fama; Devin Prouty; Sandra A Brown; Kevin Cummins; Wesley K Thompson; Ian M Colrain; Fiona C Baker; Michael D De Bellis; Stephen R Hooper; Duncan B Clark; Tammy Chung; Bonnie J Nagel; B Nolan Nichols; Torsten Rohlfing; Weiwei Chu; Kilian M Pohl; Adolf Pfefferbaum
Journal:  Neuropsychology       Date:  2016-01-11       Impact factor: 3.295

2.  Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer's disease.

Authors:  Kathryn V Papp; Rebecca E Amariglio; Elizabeth C Mormino; Trey Hedden; Maria Dekhytar; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Neuropsychologia       Date:  2015-05-19       Impact factor: 3.139

3.  Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults.

Authors:  Brian S Mohlenhoff; Philip S Insel; R Scott Mackin; Thomas C Neylan; Derek Flenniken; Rachel Nosheny; Anne Richards; Paul Maruff; Michael W Weiner
Journal:  J Clin Sleep Med       Date:  2018-09-15       Impact factor: 4.062

4.  Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.

Authors:  Annie M Racine; Lindsay R Clark; Sara E Berman; Rebecca L Koscik; Kimberly D Mueller; Derek Norton; Christopher R Nicholas; Kaj Blennow; Henrik Zetterberg; Bruno Jedynak; Murat Bilgel; Cynthia M Carlsson; Bradley T Christian; Sanjay Asthana; Sterling C Johnson
Journal:  J Alzheimers Dis       Date:  2016-10-18       Impact factor: 4.472

5.  Comparison of PC and iPad administrations of the Cogstate Brief Battery in the Mayo Clinic Study of Aging: Assessing cross-modality equivalence of computerized neuropsychological tests.

Authors:  Nikki H Stricker; Emily S Lundt; Kelly K Edwards; Mary M Machulda; Walter K Kremers; Rosebud O Roberts; David S Knopman; Ronald C Petersen; Michelle M Mielke
Journal:  Clin Neuropsychol       Date:  2018-11-10       Impact factor: 3.535

6.  Lorazepam Challenge for Individuals at Varying Genetic Risk for Alzheimer Disease.

Authors:  Cynthia M Stonnington; Brian Harel; Dona E C Locke; Joseph G Hentz; Nan Zhang; Paul Maruff; Richard J Caselli
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Oct-Dec       Impact factor: 2.703

7.  "Cognitive, emotion control, and motor performance of adolescents in the NCANDA study: Contributions from alcohol consumption, age, sex, ethnicity, and family history of addiction": Correction to Sullivan et al. (2016).

Authors: 
Journal:  Neuropsychology       Date:  2016-08-08       Impact factor: 3.295

8.  Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.

Authors:  Michelle M Mielke; Mary M Machulda; Clinton E Hagen; Teresa J Christianson; Rosebud O Roberts; David S Knopman; Prashanthi Vemuri; Val J Lowe; Walter K Kremers; Clifford R Jack; Ronald C Petersen
Journal:  Alzheimers Dement       Date:  2015-11-19       Impact factor: 21.566

9.  Brain Network Segregation and Glucose Energy Utilization: Relevance for Age-Related Differences in Cognitive Function.

Authors:  Peter Manza; Corinde E Wiers; Ehsan Shokri-Kojori; Danielle Kroll; Dana Feldman; Melanie Schwandt; Gene-Jack Wang; Dardo Tomasi; Nora D Volkow
Journal:  Cereb Cortex       Date:  2020-10-01       Impact factor: 5.357

Review 10.  Novel Cognitive Paradigms for the Detection of Memory Impairment in Preclinical Alzheimer's Disease.

Authors:  David A Loewenstein; Rosie E Curiel; Ranjan Duara; Herman Buschke
Journal:  Assessment       Date:  2017-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.